290 scientists return to India; developed 33 products and established two start-ups

2018-02-21 05:08:18

290 scientists have come back and joined various scientific organizations/universities in the last few years under the Prof. Ramalingaswami Re-entry Fellowship and have produced 883 papers, developed 53 technologies, 33 patents and two start-ups.By Team ABLEUnion Minister for Science & Technology and Earth Sciences Dr Harsh Vardhan lamented that several basic problems in India still remains, e

Read more

Biotechnology Entrepreneurship Students Team (BEST) 2017 Winners Announced …

2018-02-18 01:42:27

The 2017 BEST Winners were announced on February 15, 2017. Twenty teams presented their business concepts to a six-member Jury chaired by Dr P M Murali, President, ABLE. The team from Rajalakshmi College of Engineering, Chennai won the first prize. By Team ABLEThe 2017 BEST Winners were announced on February 15, 2017 on the concluding day of the four-day BEST workshop in Bangalore. Twenty teams pr

Read more

Conclave to discuss Ramalingaswami Re-entry Fellowship Program organized in New Delhi

2018-02-17 14:59:05

On the successful completion of ten years, DBT is hosting a conclave meeting to celebrate the achievements and revisit the journey of the program over the years. By Team ABLEThe Ramalingaswami Re-entry Fellowship was conceived in the year 2006-07 with the idea of encouraging scientists (Indian Nationals) working outside the country and would like to return to the home country to pursue their

Read more

US FDA grants AstraZeneca’s Selumetinib Orphan Drug Designation for neurofibromatosis treatment

2018-02-17 14:57:30

Neurofibromatosis type 1 is an incurable genetic condition that affects one in 3,000 birthsBy Team ABLEAstraZeneca and Merck have announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1).NF1 is an incurable genetic condition that affects one in 3,000 births, with high

Read more

Union Minister launches E-Auction Portal & ERP for Medical Devices Sector at Indian Medical Device 2018

2018-02-17 14:55:59

An unique e-Auction tech transfer portal exclusively dedicated for Medical Technologies and an Enterprise Resource Planning (ERP) software for Medical Device Manufacturers were launched.By Team ABLEOrganized by Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India in partnership with Federation of Indian Chambers of Commerce & Industry (FICCI), the India Medical

Read more

‘Namo-Care’ to turn India into largest pharma manufacturer in the world in three years: Minister Ananthkumar

2018-02-17 14:53:37

The Government will start rolling out Namo-Care in the next three months. The Government intends to come up with a New Pharma Policy which will unify and synergize its various components of pharma and medical devices sectors, such as Drug Price Control Order.By Team ABLE“Ayushman Bharat health insurance scheme announced by the Government, popularly called as ‘Namo-Care’, has the potential to

Read more

India’s progress in Science & Technology is exponential: Union Health Minister Dr Harsh Vardhan

2018-02-17 14:48:55

On February 15th, Dr Harsh Vardhan was talking to school children, at his residence to see a limited exhibition, showcasing advancements in Science & Technology in India. By Team ABLEUnion Minister for Science & Technology; Environment, Forest & Climate Change Dr. Harsh Vardhan has said that India’s progress in the field of science and technology is exponential and science can addres

Read more

Indian Patent Office grants Oxford BioDynamics’ EpiSwitch patent protection

2018-02-15 10:57:51

EpiSwitch is a proprietary industrial platform for the discovery, evaluation, validation and monitoring of a novel class of epigenetic biomarkers known as \'chromosome conformation signatures\' (CCSs).By Team ABLEOxford BioDynamics’ novel technology platform EpiSwitch has received patent protection in India. Oxford BioDynamics was spun out of Oxford University in 2007 and aims to translate scien

Read more

Reminder call for Grand Challenges Explorations India Round 4 announced

2018-02-15 10:55:57

Grand Challenges India is a partnership framework for DBT, BIRAC, and the Bill & Melinda Gates Foundation to launch joint initiatives aimed at catalyzing innovative health within India.By Team ABLEThe goal of the Grand Challenges Explorations (GCE) India program is to empower ideas - ideas that will create new drugs, diagnostics, devices, vaccines, delivery systems and service models that can

Read more

Sun Pharma Science Foundation recognizes Indian scientists for exemplary contribution in pharma & medical science

2018-02-15 09:36:07

The Sun Pharma Science Awards are awarded to Indian Scientists for their outstanding work and exemplary contribution to medical research. By Team ABLEThe Sun Pharma Science Foundation, a non-profit organization registered under Societies Registration Act announced the Sun Pharma Science Awards to Indian Scientists for their outstanding work and exemplary contribution to medical research. These awa

Read more